A team of researchers at the Medical University of South Carolina has discovered that a commonly used drug, N-acetylcysteine (NAC), could help reduce pain after surgery.
Clinical stage biopharmaceutical company Nacuity Pharmaceuticals announced that the US FDA has granted Fast Track designation for its NPI-001 (N-acetylcysteine amide) tablets, a proprietary ...
NPI-001 is a proprietary, GMP-grade formulation of N-acetylcysteine amide (NACA) tablets being developed to target oxidative stress associated with diseases such as retinitis pigmentosa.